| Name | Title | Contact Details |
|---|
Tissuenet is a Orlando, FL-based company in the Business Services sector.
JAGGAER is a global leader in procurement and enterprise commerce solutions, established in 1995. Originally founded as SciQuest in North Carolina, the company has grown into a multinational organization with a presence in North America, Latin America, Europe, Australia, Asia, and the Middle East. JAGGAER serves over 1,250 customers, including Fortune 10 and Fortune 100 companies, and focuses on intelligent source-to-pay (S2P) and supplier collaboration platforms. The company offers a comprehensive Source-to-Pay Suite that automates procurement processes, including eProcurement, contract management, and supplier management. JAGGAER also provides tools for supplier onboarding and risk management, along with AI-powered analytics for spend analysis and decision-making. With access to a managed supplier network of 4.2 million suppliers and 1.5 billion catalogs, JAGGAER supports a wide range of industries, including education, government, and life sciences. The companys mission is to create a responsible and efficient procurement ecosystem through innovative solutions.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
Leemis Marketing Consultants is a Oakbrook Terrace, IL-based company in the Business Services sector.